NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in...
Data Show Statistically Significant Improvements in Pain, Function and Tendon Structure in Appropriately Dosed PatientsGLASGOW, Scotland, Oct. 28, 2025 (GLOBE...
Approvals received from World Health Organization and United States Adopted Names Council establishing “xelafaslatide” as nonproprietary name for ONL1204 Ophthalmic...
Remedy Robotics selected as Mission Thrombectomy's exclusive robotics partner to broaden access to life-saving stroke treatment in the U.S. and...
KYV-101 resulted in a profound reduction in disease-associated autoantibodies and impact on disease activity in patients with difficult-to-treat rheumatoid arthritis...
Late-breaking positive Phase III data from ianalumab NEPTUNUS-1 and NEPTUNUS-2 trials in Sjögren’s disease to be presented Biomarker data informing...
HABRI and Mental Health America Partner to Offer Practical Information for Current and Prospective Pet Owners on the Mental Health...
The completely new in-the-ear hearing aid style is the world's first solution where users don't need to compromise between in-the-ear...
Insights from 1,300+ therapists highlight the trends, challenges, and innovations shaping the next era of care. BOSTON, Oct. 21, 2025...
TORONTO, Oct. 20, 2025 /PRNewswire/ -- ManagingLife, creators of the Manage My Pain platform, today announced the launch of Solace,...
Multi-omics study utilizing electronic genome mapping (EGM) reveals 70% of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) have psychiatric comorbidities...
San Diego, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Endure Biotherapeutics, Inc. (Endure Bio®), a pioneer in engineered engraftable microbial therapeutics,...
New contribution will help expand access to care by strengthening the Patient Advocate Foundation's capacity to deliver essential services and...
On track to initiate TRX319 Phase 1/2a dose-escalation trial in early 2026 TRX319 is an allogeneic CAR-Tr1 Treg cell therapy...
Remedy Robotics has been selected by the Australian Stroke Alliance as its exclusive robotics partner to expand access to endovascular thrombectomy,...
The free, online event at 7 p.m. ET on Tuesday, November 11, 2025, will feature presentations from patient advocate Jessie...
– An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in...
New Oracle Health Connection Hub delivers single, unified console to enable data sharing control, auditing, and governance so health systems...
– Data demonstrate ATH434 slows disease progression and stabilizes orthostatic hypotension – – New analysis increases overall confidence in the...
The Fund for Congolese Women named 2025 .ORG of the Year, selected from nearly 3,000applicants from more than 120 countries...